2nd Biomarkers Conference 2017

27 April- 28 April

Applications for Speaker Positions for 2017 Open

2 days of informative, scientific and business development presentations, workshops, 1 to 1 meetings , speed networking sessions and interactive corporate exhibition.

Over 50 attendees representing leading pharmaceutical organisations and global biotechnology companiesand internationally renowned academic institutions

60 presentations, case studies, workshops and panel discussions focused on the key issues in biomarker drug discovery and development, clinical applications and companion diagnostics.

4 interactive streams:

  • Biomarkers in Drug Discovery and Development
  • Clinical Biomarker Assay Development
  • Developing Companion Diagnostics
  • Advancement in Biomarker Research

20 pre-scheduled one to one meetings, exhibition and informal networking opportunities

 A Biomarker is an identifiable and measurable chracteristic, which identifies the severity and/or occurrence of a specific disease.  It has major applications in the discovery and development of novel therapeutic drugs.  Generating annual sales of  $ 17.5 billion in 2013 (RnR Market Research Report) global biomarkers , continue to play a vital role in the discovery and development of novel therapeutic drugs. Anticipated steady growth at an annual rate of 18.5% suggests the revenues will reach over $ 40.8 billion by 2018 (RnR Market Research Report)

Primarily driven by the oncology market, the indutry's window will significantly widen. In particular the need to screen and detect tumour cells earlier is expected to propel the market for oncology biomarkers, which is projected to grow at the highest rate over the next 5 years.  Earlier detection can help eliminate the need for invasive treatments, often required when cancer is discovered at too late a stage.

Discovery technology advances, an increase in partnerships and collaborations to bolster biomarker research, a boost in government and private sector investments and funds for biomarker discovery, and FDA backing for biomarker development and the driving forces behind that trend, RnR Market Research says in a Report.  But the forecast report points out that challenges in the market still exist. For example the high capital investment and low benefit-cost ratio associated with biomarkers.  The biomarker validation procedure is also burdensome, and sample collection and storage remain barriers to market growth.

The key players in this market are Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S), GlaxoSmithKline, PLC, (UK), Siemens Healthcare (Germany), Aboott Laboratories, Inc (USA), GE Healthcare (U.K), Affymetrix, Inc (U.S), Thermo Fisher Scientific, Inc (U.S), Epigenomics AG (Germany), Eisai Co Ltd (Japan), Bio-Rad Laboratories, Inc (U.S), Eli Lilly and Company (U.S), Merck & Co. (U.S) , Genomic Health Inc. (U.S), and Agilent Technologies Inc (U.S)

Dear Industry Colleagues,

Appel Consulting Ltd Reserves the Right not to publish the names of speakers for the congress.

For further information on the congress please email Mr Rosario Critelli.

Please email rosario.critelli@appelconsulting.co.uk

Please note that this event is private.

Dear Industry Colleagues,

Appel Consulting Ltd Reserves the Right not to publish the names of speakers for the congress.

For further information on the congress please email Mr Rosario Critelli.

Please email rosario.critelli@appelconsulting.co.uk

Please note that this event is private.

Dear Industry Colleagues,

Appel Consulting Ltd Reserves the Right not to publish the names of workshop leaders for the congress.

For further information on the congress please email Mr Rosario Critelli.

Please email rosario.critelli@appelconsulting.co.uk

Please note that this event is private.

PLATINUM SPONSORS 2015 BIOMARKERS

 

http://www.siliconbiosystems.com/

Media Partners

PharmaVOICE magazine provides commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 25,000 BPA-qualified subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.

SelectScience.net is the leading online product and application publication for laboratory scientists featuring the latest news, application articles, videos, product directory and product reviews. Membership is fast, free and provides access to all of the SelectScience services. SelectScience.tv is a unique video news channel for laboratory application and product information.

 

 

PharmiWeb.com is the leading jobs and news portal for the pharmaceutical, biotech and life sciences sector. Constantly updated with the latest events, features, news and thousands of jobs from all the leading employers in the sector. PharmiWeb.com is brought to you by innovative online publisher and e-business solutions provider, PharmiWeb Solutions.

 

Genetic Engineering & Biotechnology News (GEN)  is the most authoritative and widely read biotechnology news publication in the world.  Published 21 times a year, GEN's unique news and technology content  focus includes  the entire  bioproduct life cycle from early-stage R&D to applied  research and bioprocess through to commercialization. GENis  the only publication that  provides  the full  range of the biotechnology market coverage  in areas such as omics, drug and biomarker discovery, bioprocessing, clinical research, molecular diagnostics, and biobusiness.  For a free subscription, go to http://www.genengnews.com/subscriptions.aspx

 

 

Life sciences business intelligence firm Cutting Edge Information offers customized consulting and a growing library of targeted and insightful primary/secondary research reports that its competition cannot. Executives at more than 400 pharmaceutical and biotech firms have used Cutting Edge Information’s comprehensive, original pharmaceutical and benchmarking data and consulting services to make critical decisions on issues of both strategy and tactics.

 

GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.

Warwick Geneva Hotel, 14 Rue De Lausanne Gent, GE, 1201, Schweiz, 0445118477, Zu einheitlichen Tarifen

4* luxury venue Warwick Geneva.  The location is minutes from lake Geneva, the Patel Philippe Museum, the Museum of Modern Contemporary Art. Hotel Warwick Geneva offers a cosmopolitan atmosphere to precisely match the city while operating only at the highest levels of excellence.i

warwickhotels.com/geneva/

Phone:
02087121194

Email:
info@appelconsulting.co.uk

Accommodation is included in the registration fee.

Biomarkers 2015 Conference Feedback

Huw Ricketts, EMEA Regional Account Manager-Pharma, NanoString Technologies Inc.

“ The venue and catering were excellent” “ Great speakers”

Farideh Bischoff, Executive Director, Silicon Biosystem

“The subject matter was of high interest” “ The speakers were great”

Jan Voskuil, Chief Scientific Officer, Everest Biotech

“Good experience with excellent contributions”

Richard Holman, Laboratory Manager, Fisher BioService

“The meeting was very informative and interesting” “ Very good venue and facilities”